首页> 美国卫生研究院文献>Journal of Clinical Laboratory Analysis >Significance of serum IgA levels and serum IgA/C3 ratio in diagnostic analysis of patients with IgA nephropathy
【2h】

Significance of serum IgA levels and serum IgA/C3 ratio in diagnostic analysis of patients with IgA nephropathy

机译:血清IgA水平和血清IgA / C3比值在IgA肾病患者诊断分析中的意义

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Diagnostic analysis of clinical markers including serum IgA levels and serum IgA/C3 ratio in patients with IgA nephropathy is described. One hundred patients with IgA nephropathy (IgA nephropathy group) and 100 patients with other primary glomerular diseases (non‐IgA nephropathy group) were examined. The analysis was performed to distinguish between these two groups using four clinical markers: 1) more than five red blood cells in urinary sediments, 2) persistent proteinuria (urinary protein of more than 0.3 g/day), 3) serum IgA levels of more than 315 mg/dl, and 4) a serum IgA/C3 ratio of more than 3.01. Patients with three or four clinical markers were easily diagnosed as having IgA nephropathy in this study. Furthermore, there was a significant difference in these clinical markers between the good prognosis and relatively good prognosis groups (Groups I and II) and the relatively poor prognosis and poor prognosis groups (Groups III and IV) of IgA nephropathy patients. It appears that the presence of microscopic hematuria and/or persistent proteinuria, high serum IgA levels, and the serum IgA/C3 ratio are useful for distinguishing IgA nephropathy from other primary renal diseases. It is postulated that these clinical markers are also useful for diagnosis of IgA nephropathy without renal biopsy. J. Clin. Lab. Anal. 17:73–76, 2003. © 2003 Wiley‐Liss, Inc.
机译:描述了对IgA肾病患者血清IgA水平和IgA / C3比的临床标志物的诊断分析。检查了100例IgA肾病患者(IgA肾病组)和100例其他原发性肾小球疾病患者(非IgA肾病组)。使用四种临床标志物进行了分析以区分这两组:1)尿沉渣中的红细胞超过五个,2)持续性蛋白尿(尿蛋白超过0.3 g /天),3)血清IgA水平更高大于315 mg / dl,以及4)血清IgA / C3比大于3.01。在这项研究中,具有三个或四个临床标志物的患者很容易被诊断为患有IgA肾病。此外,这些临床标志物在IgA肾病患者的良好预后和相对较好的预后组(I和II组)与相对较差的预后和较差的预后组(III和IV组)之间存在显着差异。似乎存在微观血尿和/或持续性蛋白尿,高血清IgA水平和血清IgA / C3比值可用于区分IgA肾病和其他原发性肾脏疾病。假设这些临床标志物也可用于无需肾脏活检的IgA肾病的诊断。 J.临床实验室肛门17:73–76,2003.©2003 Wiley-Liss,Inc.

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号